Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03901573
Title High-Risk Skin Cancers With Atezolizumab Plus NT-I7
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NeoImmuneTech
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Northwestern University Chicago Illinois 60208 United States Details
Dana Farber Boston Massachusetts 02215 United States Details
MGH Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Mt Sinai New York New York 10029 United States Details
Cleveland Clinic Cleveland Ohio 44106 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field